NaCl 5 % Dispersa
NaCl 5 % Dispersa is a medicine authorised by Swissmedic under authorisation number 47039. The authorisation holder is OmniVision AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 17 March 1986 and the authorisation is valid without a time limit. ATC code S01XA03 places the medicine in the group Ophthalmologicals.
| Authorisation number | 47039 |
|---|---|
| Name | NaCl 5 % Dispersa |
| Full name | NaCl 5 % Dispersa, Augentropfen |
| Authorisation holder | OmniVision AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | S01XA03 |
| First authorisation | 17 March 1986 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | NaCl 5 % Dispersa, Augentropfen | B | 17 March 1986 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 10 | 10 | ml | S01XA03 | 11.99.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is NaCl 5 % Dispersa authorised in Switzerland?
Yes. NaCl 5 % Dispersa is authorised by Swissmedic under authorisation number 47039, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does NaCl 5 % Dispersa have?
NaCl 5 % Dispersa is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of NaCl 5 % Dispersa?
The authorisation holder is OmniVision AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.